NEWS RELEASE 6-AUG-2021 Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, reveals study Peer-Reviewed Publication UNIVERSITY OF BIRMINGHAM A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in theContinue reading “Licensed drug could reduce SAR | EurekAlert! Science News Releases”